Clinical Trial Update: Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for continuous infusion ceftolozane/tazobactam in infective exacerbations of cystic fibrosis and bronchiectasis, with ongoing stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Cystic Fibrosis

Drugs mentioned

• Ceftolozane/Tazobactam (ceftolozane/tazobactam)

Snippet

Sponsor: Sunshine Coast Hospital and Health Service | Conditions: Bronchiectasis, Cystic Fibrosis | Phase 4 | Status: UNKNOWN